VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 374 filers reported holding VANECK VECTORS ETF TR in Q2 2017. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $243,000 | +7.5% | 9,517 | -5.7% | 0.29% | -8.3% |
| Q1 2019 | $226,000 | +3.7% | 10,087 | -2.3% | 0.31% | +6.4% |
| Q4 2018 | $218,000 | -7.2% | 10,327 | -18.6% | 0.30% | +34.1% |
| Q3 2018 | $235,000 | -44.6% | 12,683 | -33.3% | 0.22% | -43.4% |
| Q2 2018 | $424,000 | -51.6% | 19,025 | -52.3% | 0.39% | -57.6% |
| Q1 2018 | $876,000 | -9.4% | 39,860 | -4.2% | 0.92% | -7.1% |
| Q4 2017 | $967,000 | +3.0% | 41,596 | +1.7% | 0.99% | -14.0% |
| Q3 2017 | $939,000 | -3.1% | 40,881 | -6.8% | 1.15% | -21.7% |
| Q2 2017 | $969,000 | +27.3% | 43,881 | +31.5% | 1.47% | +39.2% |
| Q1 2017 | $761,000 | +55.0% | 33,381 | +42.2% | 1.05% | +53.6% |
| Q4 2016 | $491,000 | -20.9% | 23,481 | 0.0% | 0.69% | -33.7% |
| Q3 2016 | $621,000 | -4.6% | 23,481 | 0.0% | 1.03% | -5.3% |
| Q2 2016 | $651,000 | – | 23,481 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |